ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4

Ablynx, a Sanofi company · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
healthy volunteers, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 902317
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.